Early and multiple origins of metastatic lineages within primary tumors
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Significance: The knowledge that cancer is an evolutionary process is old, but only recently can sequencing technology provide data for clinically relevant evolutionary analyses of cancer. Approaches developed for evolutionary biology can reveal the relationship among clonal lineages, the ancestral states of gene sequences, and the timing of evolutionary events. We performed whole exome sequencing of cancer tissues from multiple sites of dozens of subjects, demonstrating nonlinear patterns of tumor progression and early origins of metastatic lineages and quantifying the times of occurrence of driver mutations. These findings direct research attention away from the search for genes that induce metastasis toward genes that are mutated early in tumorigenesis, providing therapeutic targets effective against both primary tumors and metastases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
MrBayes 3.2: Efficient Bayesian Phylogenetic Inference and Model Choice Across a Large Model Space
Ronquist, F., Teslenko, M., van der Mark, P., Ayres, D. L., Darling, A., Höhna, S., Larget, B., Liu, L., Suchard, M. A., & Huelsenbeck, J. P. (2012) · Systematic Biology · doi:10.1093/sysbio/sys029 · Cited by 27,843 · cited 3×
“Ronquist F, et al. (2012) MrBayes 3.2: Efficient Bayesian phylogenetic inference and model choice across a large model space.”
MethodInfluentialPAML 4: Phylogenetic Analysis by Maximum Likelihood
Yang, Z. (2007) · Molecular Biology and Evolution · doi:10.1093/molbev/msm088 · Cited by 13,879 · cited 2×
“7 (29), which accommodates rate heterogeneity, including increases in the rate of mutations (31) among tumor tissues over time and across the phylogeny.”
BackgroundMethodPAUP^* : Phylogenetic Analysis Using Parsimony (and other methods) 4.0b8
Swofford, D. L. (2001) · Cited by 12,789
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Zwickl, D. J. (2006) · Texas ScholarWorks (Texas Digital Library) · Cited by 3,530
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256 · cited 1×
“The potential to therapeutically target these longstanding drivers of cancer continues to evolve, including targeting TP53 via the TP53/MDM2 interaction (20), targeting KRAS via KRAS G12C (21), targeting posttranslational modifications of KRAS (22), or targeting upstream or downstream effectors (23).”
BackgroundDiscovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649 · cited 2×
“distant metastases? Eur J Cancer 41(4):508–515.”
BackgroundK-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557 · cited 2×
“Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM (2013) K-Ras(G12C) inhibitors al- losterically control GTP affinity and effector interactions.”
BackgroundThe causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
Gerlinger, M., Horswell, S., Larkin, J., Rowan, A. J., Salm, M. P., Varela, I., Fisher, R., McGranahan, N., Matthews, N., Santos, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2891 · Cited by 1,208 · cited 3×
“Although ascertaining variable degrees of tumor heterogeneity (1) by computational analyses of subclonality within primary tumors has proven challenging (8), another approach to revealing heterogeneity is analysis of the sequence divergence of major clones extracted from distant sites.”
BackgroundComputational Molecular Evolution
Yang, Z. (2006) · doi:10.1093/acprof:oso/9780198567028.001.0001 · Cited by 1,148
Parallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2627 · Cited by 1,133 · cited 1×
“Therefore, early genetic divergence of metastases favors a parallel model (16) in which frequently disseminated cancer cells rarely establish themselves, rather than a linear model (13) of cancer evolution requiring somatic mutations to produce metastases.”
BackgroundA Big Bang model of human colorectal tumor growth
Sottoriva, A., Kang, H., Ma, Z., Graham, T. A., Salomon, M. P., Zhao, J., Marjoram, P., Siegmund, K., Press, M. F., Shibata, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3214 · Cited by 1,015
K + Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
Choi, M., Scholl, U. I., Yue, P., Björklund, P., Zhao, B., Nelson-Williams, C., Ji, W., Cho, Y., Patel, A., Men, C. J., et al. (2011) · Science · doi:10.1126/science.1198785 · Cited by 1,004
Self-citationThe CORGI Consortium, Palles, C., The WGS500 Consortium, Cazier, J.-B., Howarth, K. M., Domingo, E., Jones, A. M., Broderick, P., Kemp, Z., Spain, S. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2503 · Cited by 997
Rate, molecular spectrum, and consequences of human mutation
Lynch, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912629107 · Cited by 792 · cited 1×
“4 × 10 site·y (32), scaled to the observed potential doubling time (Tpot) and SD for each specific tumor (12).”
BackgroundDNA MISMATCH REPAIR AND GENETIC INSTABILITY
Harfe, B. D., & Jinks-Robertson, S. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.359 · Cited by 608 · cited 1×
“0001, Fisher’s exact test) after removing hypermutated subject 430 (24).”
BackgroundRegulating the regulator: post-translational modification of RAS
Ahearn, I. M., Haigis, K., Bar-Sagi, D., & Philips, M. R. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3255 · Cited by 557
DNA Mismatch Repair: Molecular Mechanisms and Biological Function
Schofield, M. J., & Hsieh, P. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090847 · Cited by 492
Miller, C. A., White, B. S., Dees, N. D., Griffith, M., Welch, J. S., Griffith, O. L., Vij, R., Tomasson, M. H., Graubert, T. A., Walter, M. J., et al. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003665 · Cited by 454 · cited 1×
“Although ascertaining variable degrees of tumor heterogeneity (1) by computational analyses of subclonality within primary tumors has proven challenging (8), another approach to revealing heterogeneity is analysis of the sequence divergence of major clones extracted from distant sites.”
BackgroundWood, R. D., Mitchell, M., & Lindahl, T. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2005.03.007 · Cited by 424
Tomasetti, C., Vogelstein, B., & Parmigiani, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221068110 · Cited by 414 · cited 1×
“Because mutations in self-renewing tissues are cumulative over time and directly correlated with age (30), we used a molecular clock phylogenetic approach to infer the order of genetic divergence of tumors, calibrating it with the timings of diagnosis, biopsy, and/or surgical resection of the primary tumor.”
MethodMutation in the Mismatch Repair Gene Msh6 Causes Cancer Susceptibility
Edelmann, W., Yang, K., Umar, A., Heyer, J., Lau, K., Fan, K., Liedtke, W., Cohen, P. E., Kane, M. F., Lipford, J. R., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80433-x · Cited by 365
Wang, S., Sun, W., Zhao, Y., McEachern, D., Meaux, I., Barrière, C., Stuckey, J. A., Meagher, J. L., Bai, L., Liu, L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0799 · Cited by 328 · cited 1×
“The potential to therapeutically target these longstanding drivers of cancer continues to evolve, including targeting TP53 via the TP53/MDM2 interaction (20), targeting KRAS via KRAS G12C (21), targeting posttranslational modifications of KRAS (22), or targeting upstream or downstream effectors (23).”
BackgroundRecurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
Goh, G., Scholl, U. I., Healy, J. M., Choi, M., Prasad, M. L., Nelson-Williams, C., Kunstman, J. W., Korah, R., Suttorp, A.-C., Dietrich, D., et al. (2014) · Nature Genetics · doi:10.1038/ng.2956 · Cited by 251 · cited 1×
“Genomic DNA was extracted from FFPE core biopsies using the BiOstic FFPE Tissue DNA isolation kit (MO BIO) following standard procedures that we have used successfully in the past to recover single nucleotide variants (26).”
MethodSelf-citationBaum, M., Demicheli, R., Hrushesky, W., & Retsky, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.09.031 · Cited by 190 · cited 1×
“The observed early genetic divergence of metastases has implications for the retrospective examination of medical care, including whether surgery is seeding distant metastases (17).”
BackgroundGonadotropins and Ovarian Cancer
Choi, J., Wong, A. S. T., Huang, H., & Leung, P. C. K. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0036 · Cited by 188
Hynes, R. O. (2003) · Cell · doi:10.1016/s0092-8674(03)00468-9 · Cited by 173
Weinberg, R. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90177-s · Cited by 155
Using tumour phylogenetics to identify the roots of metastasis in humans
Naxerova, K., & Jain, R. K. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.238 · Cited by 154 · cited 2×
“Hynes RO (2003) Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell 113(7):821–823.”
BackgroundPhylogenetic Signal and Noise: Predicting the Power of a Data Set to Resolve Phylogeny
Townsend, J. P., Su, Z., & Tekle, Y. I. (2012) · Systematic Biology · doi:10.1093/sysbio/sys036 · Cited by 144
Self-citationCell production rates in human tissues and tumours and their significance. Part II: clinical data
Rew, D. A., & Wilson, G. D. (2000) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0907 · Cited by 131 · cited 2×
“calibrated these phylogenies with tumor type-specific data on tumor cell division times (12) and with the clinical timings of diagnosis, biopsy, resection, and autopsy for each patient (Datasets S5 and S6) to evaluate the evolutionary pattern and tempo of the genetic divergence of primary and metastatic tumor lineages…”
BackgroundMethodEvidence emerges for early metastasis and parallel evolution of primary and metastatic tumors
Gray, J. W. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00167-3 · Cited by 113 · cited 1×
“They suggest that clinical treatments addressing genetically heterogeneous metastases could be warranted even when the sole diagnosis is of a primary tumor (18).”
BackgroundCancer Evolution Is Associated with Pervasive Positive Selection on Globally Expressed Genes
Ostrow, S. L., Barshir, R., DeGregori, J., Yeger-Lotem, E., & Hershberg, R. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004239 · Cited by 100
Fundamental study on the mechanism of DNA degradation in tissues fixed in formaldehyde.
Tokuda, Y., Nakamura, T., Satonaka, K., Maeda, S., Doi, K., Baba, S., & Sugiyama, T. (1990) · Journal of Clinical Pathology · doi:10.1136/jcp.43.9.748 · Cited by 99
Molecular and genetic diversity in the metastatic process of melanoma
Harbst, K., Lauss, M., Cirenajwis, H., Winter, C., Howlin, J., Törngren, T., Kvist, A., Nodin, B., Olsson, E., Häkkinen, J., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4318 · Cited by 77 · cited 4×
“Sukumaran J, Holder M (2008) SumTrees, Summarization of Split Support on Phylogenetic Trees (part of the DendroPy Phylogenetic Computation Library), Version 2(3).”
BackgroundInfluentialDistribution of Renal Tumor Growth Rates Determined by Using Serial Volumetric CT Measurements
Zhang, J., Kang, S. K., Wang, L., Touijer, A. K., & Hricak, H. (2008) · Radiology · doi:10.1148/radiol.2501071712 · Cited by 69
Vasan, N., Yelensky, R., Wang, K., Moulder, S., Dzimitrowicz, H. E., Avritscher, R., Wang, B., Wu, Y., Cronin, M. T., Palmer, G. A., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0377 · Cited by 64 · cited 1×
“Although many studies have identified therapeutically targetable alterations associated with late-stage tumors (25), evolutionary analyses of the timing of mutations in driver genes in cancerous tissues will be important not only because pharmaceutical treatment could have a large therapeutic effect on tumors exhibiti…”
BackgroundInferring the Origin of Metastases from Cancer Phylogenies
Hong, W. S., Shpak, M., & Townsend, J. P. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1889 · Cited by 49 · cited 1×
“There are many additional questions about the process of metastasis that cannot be addressed without more complex models of the processes underlying tumorigenesis and metastasis and comprehensive intratumor sampling (15).”
BackgroundSelf-citationMicroscopic mechanism of DNA damage searching by hOGG1
Rowland, M. M., Schonhoft, J. D., McKibbin, P. L., David, S. S., & Stivers, J. T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku621 · Cited by 45
Cell kinetics in vivo of human breast cancer
Stanton, P. D., Cooke, T. G., Forster, G., Smıth, D. J., & Going, J. J. (1996) · British journal of surgery · doi:10.1002/bjs.1800830130 · Cited by 34
Cited by
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
Turajlic, S., Xu, H., Litchfield, K., Rowan, A., Chambers, T., Lopez, J. I., Nicol, D., O’Brien, T., Larkin, J., Horswell, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.057 · Cited by 829
Metastasis as an evolutionary process
Turajlic, S., & Swanton, C. (2016) · Science · doi:10.1126/science.aaf2784 · Cited by 661
Quantitative evidence for early metastatic seeding in colorectal cancer
Hu, Z., Ding, J., Ma, Z., Sun, R., Seoane, J. A., Scott Shaffer, J., Suarez, C. J., Berghoff, A. S., Cremolini, C., Falcone, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0423-x · Cited by 490
Hu, Z., Li, Z., Ma, Z., & Curtis, C. (2020) · Nature Genetics · doi:10.1038/s41588-020-0628-z · Cited by 374
Biology, vulnerabilities and clinical applications of circulating tumour cells
Ring, A., Nguyen-Sträuli, B. D., Wicki, A., & Aceto, N. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00536-4 · Cited by 327
Metadata
- Authors
- Zhao, Z.-M., Zhao, B., Bai, Y., Iamarino, A., Gaffney, S. G., Schlessinger, J., Lifton, R. P., Rimm, D. L., & Townsend, J. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2016-02-08
- Volume
- 113
- Issue
- 8
- Pages
- 2140-2145
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2270865385
- Cited by
- 158
- References
- 46
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.